Andrew Okun - PerkinElmer President
| PKIDelisted Stock | USD 115.24 0.74 0.64% |
President
Mr. Andrew Okun is Chief Accounting Officer, Vice President of PerkinElmer Inc., Mr. Okun joined us in 2001 and has served in financial and controllership positions of increasing responsibility, including Director of Finance for the Optoelectronics business from 2001 through 2005, Vice President of Finance from 2005 through 2009 and Vice President and Corporationrationrate Controller from 2009 through 2011. Prior to joining us, Mr. Okun most recently worked for Honeywell International as a Site Controller as well as for Coopers Lybrand since 2021.
| Age | 53 |
| Tenure | 3 years |
| Professional Marks | MBA |
| Phone | 781 663 6900 |
| Web | https://www.perkinelmer.com |
PerkinElmer Management Efficiency
The company has Return on Asset of 0.0369 % which means that on every $100 spent on assets, it made $0.0369 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0706 %, implying that it generated $0.0706 on every 100 dollars invested. PerkinElmer's management efficiency ratios could be used to measure how well PerkinElmer manages its routine affairs as well as how well it operates its assets and liabilities.The company has 3.92 B in debt with debt to equity (D/E) ratio of 0.65, which is OK given its current industry classification. PerkinElmer has a current ratio of 1.98, which is typical for the industry and considered as normal. Debt can assist PerkinElmer until it has trouble settling it off, either with new capital or with free cash flow. So, PerkinElmer's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PerkinElmer sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PerkinElmer to invest in growth at high rates of return. When we think about PerkinElmer's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Mark Oene | Illumina | 45 | |
| Paula Dowdy | Illumina | N/A | |
| Aimee Hoyt | Illumina | 47 | |
| David Smith | Charles River Laboratories | 58 | |
| William King | Danaher | 53 | |
| Thomas Loewald | Thermo Fisher Scientific | 52 | |
| Giovani Twigge | IDEXX Laboratories | 54 | |
| Omead Ostadan | Illumina | 46 | |
| Robert Lutz | Danaher | 62 | |
| Lisa Uthgenannt | Laboratory of | 57 | |
| Susan Hardy | Charles River Laboratories | N/A | |
| Dominique Grau | Agilent Technologies | 65 | |
| Sandra Vaart | Laboratory of | 64 | |
| Daniel Shine | Thermo Fisher Scientific | 47 | |
| Jacqueline Studer | IDEXX Laboratories | 58 | |
| Sherry Buck | Waters | 55 | |
| Angela Lalor | Danaher | 59 | |
| Karen McGinnis | Illumina | 50 | |
| Kenneth Apicerno | Thermo Fisher Scientific | N/A | |
| Samuel Eberts | Laboratory of | 57 | |
| Joakim Weidemanis | Danaher | 55 | |
Management Performance
| Return On Equity | 0.0706 | |||
| Return On Asset | 0.0369 |
PerkinElmer Leadership Team
Elected by the shareholders, the PerkinElmer's board of directors comprises two types of representatives: PerkinElmer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PerkinElmer. The board's role is to monitor PerkinElmer's management team and ensure that shareholders' interests are well served. PerkinElmer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PerkinElmer's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michel Vounatsos, Independent Director | ||
| Sylvie Gregoire, Independent Director | ||
| Pascale Witz, Independent Director | ||
| Miriame Victor, Chief Commercial Officer, Senior Vice President | ||
| Jonathan DiVincenzo, Sr. VP and President of Environmental Health | ||
| Patrick Sullivan, Independent Director | ||
| Stephen Willoughby, VP ESG | ||
| Tajinder Vohra, Senior Vice President Global Operations | ||
| Prahlad Singh, Senior Vice President and President - Diagnostics | ||
| Robert Friel, Chairman, CEO and President and Member of Fin. Committee | ||
| Vicki Sato, Independent Director | ||
| Maxwell Krakowiak, VP CFO | ||
| Daniel Tereau, Senior Vice President Strategy and Business Development | ||
| Alexandros Michas, Independent Non-Executive Chairman of the Board | ||
| Nicholas Lopardo, Lead Independent Director | ||
| Franklin Witney, Director | ||
| Joel Goldberg, Senior Vice President - Administration, General Counsel, Secretary | ||
| James Corbett, Sr. VP and President of Human Health | ||
| Kenton Sicchitano, Independent Director | ||
| Samuel Chapin, Independent Director | ||
| James Mock, Chief Financial Officer, Senior Vice President | ||
| Andrew Okun, Chief Accounting Officer, Vice President, Treasurer | ||
| Peter Barrett, Independent Director | ||
| Deborah Butters, Chief Human Resource Officer, Senior Vice President | ||
| Frank Witney, Independent Director | ||
| John Letcher, Senior Vice President - Human Resources | ||
| Alexis Michas, Independent Non-Executive Chairman of the Board | ||
| Jon DiVincenzo, Senior Vice President and Presidentident - Environmental Health | ||
| Masoud Toloue, VP Diagnostics | ||
| Frank Wilson, CFO and Sr. VP |
PerkinElmer Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PerkinElmer a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0706 | |||
| Return On Asset | 0.0369 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 22.3 B | |||
| Shares Outstanding | 126.41 M | |||
| Shares Owned By Insiders | 0.26 % | |||
| Shares Owned By Institutions | 86.25 % | |||
| Number Of Shares Shorted | 3.53 M | |||
| Price To Earning | 21.07 X |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as PerkinElmer using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in PerkinElmer Stock
If you are still planning to invest in PerkinElmer check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PerkinElmer's history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |